Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients

Cohen, C; Molina, JM; Cahn, P; Clotet, B; Fourie, J; Grinsztejn, B; Hao, W; Johnson, M; Supparatpinyo, K; Crauwels, HM; Rimsky, L; Vanveggel, S; Williams, P; Boven, K

doi:10.1186/1758-2652-13-S4-O48

Journal of the International AIDS Society

Article metrics
Last updated: Sat, 27 Apr 2024 4:29:42 Z

Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients

Access & Citations

3576

Article Accesses
0

Web of Science
10

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.